Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 7 clinical trials
Featured trial
Sequential CAR-T Cells Targeting BCMA/GPRC5D in Patients With Relapsed/ Refractory Multiple Myeloma (BAH2573)

This is an open, single-arm, clinical study to evaluate the efficacy and safety of chimeric antigen receptor T cell immunotherapy (CAR-T) targeting BCMA or GPRC5D or both sequentially in the treatment of Relapsed/ Refractory Multiple myeloma

  • 0 views
  • 24 Nov, 2025
Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection

An Open-label, prospective, randomized, comparative, multiple doses applied in addition to the standard of care treatment of patients with moderate to severe COVID-19 infection

dyspnea
covid-19
fever
pneumonia
cough
  • 0 views
  • 19 Feb, 2024
  • 1 location
Hospital Registry of Acute Myocarditis: Evolution of the Proportion of Positive SARS-COV-2 (COVID19) Cases

To date, the effects of SARS-Cov-2 (Covid-19) on the myocardium and the role it plays in the evolution towards an acute myocarditis are badly understood. The current pandemic of this emerging virus is an opportunity to assess the proportion of acute myocarditis attributable to SARS-Cov-2(Covid-19) and to assess the clinical, …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Acute Kidney Injury and Renal Outcomes for COVID-19 Patients in Intensive Care Units

Some data suggested a potential direct renal tropism of the virus, or undirect injury by "cytokine storm". The aims of this study are: To describe incidence, severity and mortality associated with AKI during covid-19 infection in ICU To identify specific risk factors for AKI To explore pathophysiologic mechanism of AKI …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Th1/Th2/Th17/TREG and TLRs Activation/KIR for COVID 19 Prediction of Outcome

To ascertain globally the changes in the cytokines involved and TLRs/KIR activation in patients admitted to the hospital with a COVID-19 diagnosis, and the changes after initiation of the different therapies

cytokines
covid-19
  • 0 views
  • 19 Feb, 2024
  • 1 location
Microvascular Flow and Reactivity in Patients Presenting in the Acute Phase of COVID-19.

Considering that the intensity of systemic microvascular changes in patients in the acute phase of COVID-19 could be related to disease progression and prognosis, the present cross-sectional and observational study aims to investigate the presence of endothelial dysfunction in these patients, also looking for to evaluate associations between the presence …

SARS
covid-19
endothelial dysfunction
acute respiratory syndrome (sars)
  • 0 views
  • 19 Feb, 2024
  • 1 location
Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches

In light of the rapidly emerging pandemic of SARS-CoV-2 infections, the global population and health care systems are facing unprecedented challenges through the combination of transmission and the potential for severe disease. Acute respiratory distress syndrome (ARDS) has been found with unusual clinical features dominated by substantial alveolar fluid load. …

microbiota
edta
acute respiratory distress syndrome
inflammatory response
respiratory tract infection
  • 0 views
  • 19 Feb, 2024
  • 1 location